Healthcare provider profile · identity verified

James P Roseto, M.D.

Internal Medicine · BOSTON, MA · NPI 1194768531

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	827	254
Amlodipine Besylate	Amlodipine Besylate	672	205
Lisinopril	Lisinopril	448	146
Omeprazole	Omeprazole	442	137
Simvastatin	Simvastatin	426	131
Hydrochlorothiazide	Hydrochlorothiazide	372	122
Metoprolol Succinate	Metoprolol Succinate	285	89
Tamsulosin Hcl	Tamsulosin Hcl	283	86
Losartan Potassium	Losartan Potassium	271	91
Gabapentin	Gabapentin	263	66
Levothyroxine Sodium	Levothyroxine Sodium	252	76
Metformin Hcl Er	Metformin Hcl	242	75
Lorazepam	Lorazepam	239	54
Eliquis	Apixaban	219	51
Warfarin Sodium	Warfarin Sodium	183	24
Pravastatin Sodium	Pravastatin Sodium	173	52
Metformin Hcl	Metformin Hcl	167	53
Rosuvastatin Calcium	Rosuvastatin Calcium	153	47
Allopurinol	Allopurinol	152	41
Oxycodone Hcl	Oxycodone Hcl	143	20
Jardiance	Empagliflozin	135	31
Atenolol	Atenolol	125	36
Finasteride	Finasteride	119	41
Albuterol Sulfate Hfa	Albuterol Sulfate	117	41
Sertraline Hcl	Sertraline Hcl	116	35
Citalopram Hbr	Citalopram Hydrobromide	115	28
Trulicity	Dulaglutide	113	20
Ozempic	Semaglutide	111	22
Spironolactone	Spironolactone	106	31
Carvedilol	Carvedilol	92	20
Clonazepam	Clonazepam	92	18
Pantoprazole Sodium	Pantoprazole Sodium	85	23
Furosemide	Furosemide	84	27
Trazodone Hcl	Trazodone Hcl	79	29
Glimepiride	Glimepiride	78	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	78	29
Alendronate Sodium	Alendronate Sodium	62	17
Fluticasone Propionate	Fluticasone Propionate	61	30
Zolpidem Tartrate	Zolpidem Tartrate	61	11
Chlorthalidone	Chlorthalidone	59	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	14
Mounjaro	Tirzepatide	56	suppressed
Pregabalin	Pregabalin	52	suppressed
Torsemide	Torsemide	52	19
Clopidogrel	Clopidogrel Bisulfate	51	18
Montelukast Sodium	Montelukast Sodium	49	14
Fluoxetine Hcl	Fluoxetine Hcl	47	16
Duloxetine Hcl	Duloxetine Hcl	46	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	12
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	44	suppressed
Mirtazapine	Mirtazapine	44	14
Ibuprofen	Ibuprofen	43	15
Terazosin Hcl	Terazosin Hcl	42	13
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	41	41
Esomeprazole Magnesium	Esomeprazole Magnesium	41	13
Potassium Chloride	Potassium Chloride	41	15
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	40	40
Escitalopram Oxalate	Escitalopram Oxalate	40	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	14
Descovy	Emtricitabine/Tenofov Alafenam	37	suppressed
Ventolin Hfa	Albuterol Sulfate	37	suppressed
Oxycontin	Oxycodone Hcl	36	suppressed
Diazepam	Diazepam	35	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Prednisone	Prednisone	33	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Bupropion Xl	Bupropion Hcl	32	13
Januvia	Sitagliptin Phosphate	32	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	32	29
Verapamil Er	Verapamil Hcl	32	suppressed
Glipizide	Glipizide	31	11
Acyclovir	Acyclovir	30	suppressed
Colchicine	Colchicine	29	15
Irbesartan	Irbesartan	29	14
Linzess	Linaclotide	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	11
Famotidine	Famotidine	28	11
Labetalol Hcl	Labetalol Hcl	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	13
Xarelto	Rivaroxaban	28	suppressed
Enalapril Maleate	Enalapril Maleate	27	12
Ezetimibe	Ezetimibe	27	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	27	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Trospium Chloride	Trospium Chloride	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	11
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Glipizide Er	Glipizide	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Prezcobix	Darunavir/Cobicistat	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	11
Topiramate	Topiramate	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Azithromycin	Azithromycin	21	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Valsartan	Valsartan	21	suppressed
Fentanyl	Fentanyl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Digoxin	Digoxin	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Tivicay	Dolutegravir Sodium	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Temazepam	Temazepam	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Dapagliflozin	Dapagliflozin Propanediol	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Naproxen	Naproxen	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Tenofovir Disoproxil Fumarate	Tenofovir Disoproxil Fumarate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Atazanavir Sulfate	Atazanavir Sulfate	12	suppressed
Efavirenz	Efavirenz	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Fluocinolone Acetonide	Fluocinolone Acetonide	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Ritonavir	Ritonavir	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Eplerenone	Eplerenone	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error